BAIETTO, LORENA
BAIETTO, LORENA
SCIENZE MEDICHE
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
2014-01-01 Baietto, L; Corcione, S; Pacini, G; Di Perri, G; D'Avolio, A; De Rosa, FG
A population pharmacokinetic model confirms an association between a pregnane-X-receptor (PXR) polymorphism and unboosted atazanavir clearance
2009-01-01 Schipani A; Siccardi M; D'Avolio A; Baietto L; Calcagno A; Tettoni C; Bonora S; Davis G; Khoo S; Back DJ; Di Perri G; Owen A
ABCB1 3435C>T e CYP2B6 516G>T possono predire le concentrazioni plasmatiche ottimali di Nevirapina
2009-01-01 Antonio D'Avolio; Marco Siccardi; Deborah Gatti; Lorena Baietto; Francesca Romana Stefani; Marco Simiele; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri
Anidulafungin for Candida glabrata Infective Endocarditis
2012-01-01 De Rosa FG; D'Avolio A; Corcione S; Baietto L; Raviolo S; Centofanti P; Pasero D; Rinaldi M; Di Perri G.
Anidulafungin pharmacokinetic evaluation in a cohort of patients
2011-01-01 F.G. De Rosa; L. Baietto; A. D’Avolio; D. Pasero; S. Raviolo; S. Pace; C. Marra; V.M. Ranieri; G. Di Perri
Are intracellular drug concentrations underestimated? The role of medium corpuscular volume (MCV) for a correct determination
2010-01-01 Marco Simiele; Antonio D’Avolio; Marco Siccardi; Lorena Baietto; Francesca Romana Stefani; Silvia Agati; Jessica Cusato; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir
2008-01-01 Marco Siccardi; Antonio D'Avolio; Lorena Baietto; Sara Gibbons; Mauro Sciandra; Daniela Colucci; Stefano Bonora; Saye Khoo; David J Back; Giovanni Di Perri; Andrew Owen
Caspofungin: is standard dosing optimal or inadequate? Pharmacokinetic description in a cohort of patients
2011-01-01 F.G. De Rosa; L. Baietto; A. D’Avolio; D. Pasero; S. Raviolo;C. Marra; S. Pace; V.M. Ranieri; G. Di Perri
Ceftriaxone bone penetration in patients with septic non-union of the tibia
2011-01-01 Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G.
Ceftriaxone cerebrospinal fluid levels in adult patients with meningoencephalitis
2015-01-01 L. Baietto; A. Calcagno; A. Romito; P. Bigliano; S. Ecclesia; R. Bertucci; F. Lipani; F.G. De Rosa; G. Di Perri; A. D'Avolio
Combined effect of SLCO1B1 521T>C, PXR 63396C>T, and ABCB1 3435C>T on the achievement of therapeutic concentrations of unboosted Atazanavir
2009-01-01 M. Siccardi; A. D’Avolio; S. Bonora; L. Baietto; D. Gatti; A. Calcagno; V. Ghisetti; M. Lanzafame; G. Penco; D. Back; A. Owen; G. Di Perri
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens.
2011-01-01 Gonzalez de Requena D; Bonora S; Viganò O; Calcagno A; Cometto C; D'Avolio A; Baietto L; Ghisetti V; Magnani S; Ferramosca S; Vitiello P; Galli M; Rusconi S; Di Perri G.
Le concentrazioni plasmatriche di ATV boostato ed unboosted correlano con il polimorfismo 63396C>T del pregnane X receptor.
2008-01-01 M. Siccardi; A. D'Avolio; L. Baietto; D. Gatti; A. Calcagno; S. Gibbons; M. Sciandra; S. Bonora; S. Khoo; D. Back; G. Di Perri; A. Owen.
Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs?
2013-01-01 Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora
Cut-off values of ribavirin trough concentration for sustained virological response and for hematological toxicity in HCV/HIV-co-infected patients treated with RBV and Pegylated Interferon
2007-01-01 Aguilar Marucco D; Gonzalez de Requena D; Veronese L; Bonora S; Ibanez A; Baietto L; D'Avolio A; Sciandra M; Sinicco A; Di Perri G
Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients
2016-01-01 D'Avolio, Antonio; Pensi, Debora; Baietto, Lorena; Pacini, Giovanni; Di Perri, Giovanni; De Rosa, Francesco Giuseppe
Daptomycin plasma and CSF levels in patients with external ventricular drain (EVD)-related ventriculo-meningitis (VM)
2014-01-01 L. Baietto; S. Piva; N. Latronico; T. Togni; G. Di Perri; A. D’Avolio
Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots.
2015-01-01 Baldelli S;Cattaneo D;Giodini L;Baietto L;Di Perri G;D'Avolio A;Clementi E
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS.
2012-01-01 Baietto L;D'Avolio A;Marra C;Simiele M;Cusato J;Pace S;Ariaudo A;De Rosa FG;Di Perri G
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
2013-01-01 Baietto, L; D'Avolio, A; Ariaudo, A; Corcione, S; Simiele, M; Cusato, J; Urbino, R; Di Perri, G; Ranieri, VM; De Rosa, FG.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? | 2014 | Baietto, L; Corcione, S; Pacini, G; Di Perri, G; D'Avolio, A; De Rosa, FG | |
| A population pharmacokinetic model confirms an association between a pregnane-X-receptor (PXR) polymorphism and unboosted atazanavir clearance | 2009 | Schipani A; Siccardi M; D'Avolio A; Baietto L; Calcagno A; Tettoni C; Bonora S; Davis G; Khoo S; Back DJ; Di Perri G; Owen A | |
| ABCB1 3435C>T e CYP2B6 516G>T possono predire le concentrazioni plasmatiche ottimali di Nevirapina | 2009 | Antonio D'Avolio; Marco Siccardi; Deborah Gatti; Lorena Baietto; Francesca Romana Stefani; Marco Simiele; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri | |
| Anidulafungin for Candida glabrata Infective Endocarditis | 2012 | De Rosa FG; D'Avolio A; Corcione S; Baietto L; Raviolo S; Centofanti P; Pasero D; Rinaldi M; Di Perri G. | |
| Anidulafungin pharmacokinetic evaluation in a cohort of patients | 2011 | F.G. De Rosa; L. Baietto; A. D’Avolio; D. Pasero; S. Raviolo; S. Pace; C. Marra; V.M. Ranieri; G. Di Perri | |
| Are intracellular drug concentrations underestimated? The role of medium corpuscular volume (MCV) for a correct determination | 2010 | Marco Simiele; Antonio D’Avolio; Marco Siccardi; Lorena Baietto; Francesca Romana Stefani; Silvia Agati; Jessica Cusato; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri | |
| Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir | 2008 | Marco Siccardi; Antonio D'Avolio; Lorena Baietto; Sara Gibbons; Mauro Sciandra; Daniela Colucci; Stefano Bonora; Saye Khoo; David J Back; Giovanni Di Perri; Andrew Owen | |
| Caspofungin: is standard dosing optimal or inadequate? Pharmacokinetic description in a cohort of patients | 2011 | F.G. De Rosa; L. Baietto; A. D’Avolio; D. Pasero; S. Raviolo;C. Marra; S. Pace; V.M. Ranieri; G. Di Perri | |
| Ceftriaxone bone penetration in patients with septic non-union of the tibia | 2011 | Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G. | |
| Ceftriaxone cerebrospinal fluid levels in adult patients with meningoencephalitis | 2015 | L. Baietto; A. Calcagno; A. Romito; P. Bigliano; S. Ecclesia; R. Bertucci; F. Lipani; F.G. De Rosa; G. Di Perri; A. D'Avolio | |
| Combined effect of SLCO1B1 521T>C, PXR 63396C>T, and ABCB1 3435C>T on the achievement of therapeutic concentrations of unboosted Atazanavir | 2009 | M. Siccardi; A. D’Avolio; S. Bonora; L. Baietto; D. Gatti; A. Calcagno; V. Ghisetti; M. Lanzafame; G. Penco; D. Back; A. Owen; G. Di Perri | |
| Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens. | 2011 | Gonzalez de Requena D; Bonora S; Viganò O; Calcagno A; Cometto C; D'Avolio A; Baietto L; Ghisetti V; Magnani S; Ferramosca S; Vitiello P; Galli M; Rusconi S; Di Perri G. | |
| Le concentrazioni plasmatriche di ATV boostato ed unboosted correlano con il polimorfismo 63396C>T del pregnane X receptor. | 2008 | M. Siccardi; A. D'Avolio; L. Baietto; D. Gatti; A. Calcagno; S. Gibbons; M. Sciandra; S. Bonora; S. Khoo; D. Back; G. Di Perri; A. Owen. | |
| Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs? | 2013 | Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora | |
| Cut-off values of ribavirin trough concentration for sustained virological response and for hematological toxicity in HCV/HIV-co-infected patients treated with RBV and Pegylated Interferon | 2007 | Aguilar Marucco D; Gonzalez de Requena D; Veronese L; Bonora S; Ibanez A; Baietto L; D'Avolio A; Sciandra M; Sinicco A; Di Perri G | |
| Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients | 2016 | D'Avolio, Antonio; Pensi, Debora; Baietto, Lorena; Pacini, Giovanni; Di Perri, Giovanni; De Rosa, Francesco Giuseppe | |
| Daptomycin plasma and CSF levels in patients with external ventricular drain (EVD)-related ventriculo-meningitis (VM) | 2014 | L. Baietto; S. Piva; N. Latronico; T. Togni; G. Di Perri; A. D’Avolio | |
| Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots. | 2015 | Baldelli S;Cattaneo D;Giodini L;Baietto L;Di Perri G;D'Avolio A;Clementi E | |
| Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS. | 2012 | Baietto L;D'Avolio A;Marra C;Simiele M;Cusato J;Pace S;Ariaudo A;De Rosa FG;Di Perri G | |
| Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots | 2013 | Baietto, L; D'Avolio, A; Ariaudo, A; Corcione, S; Simiele, M; Cusato, J; Urbino, R; Di Perri, G; Ranieri, VM; De Rosa, FG. |